Abstract
AbstractThe Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 March 2020, we enrolled 701 eligible PWID aged 18+ who lived in Toronto. Participants complete interviewer-administered questionnaires at baseline and semi-annually thereafter and are asked to consent to linkages with provincial healthcare administrative databases (90.2% consented; of whom 82.4% were successfully linked) and SCS client databases. At baseline, 86.5% of participants (64.0% cisgender men, median ([IQR] age= 39 [33–49]) had used SCS in the previous 6 months, of whom most (69.7%) used SCS for <75% of their injections. A majority (56.8%) injected daily, and approximately half (48.0%) reported fentanyl as their most frequently injected drug. As of 23 April 2021, 291 (41.5%) participants had returned for follow-up. Administrative and self-report data are being used to (1) evaluate the impact of integrated SCS on healthcare use, uptake of community health agency services, and health outcomes; (2) identify barriers and facilitators to SCS use; and (3) identify potential enhancements to SCS delivery. Nested sub-studies include evaluation of “safer opioid supply” programs and impacts of COVID-19.
Funder
Canadian Institutes of Health Research
St. Michael's Hospital Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health (social science),Urban Studies
Reference41 articles.
1. Jacka B, Larney S, Degenhardt L, Janjua N, Høj S, Krajden M, et al. Prevalence of injecting drug use and coverage of interventions to prevent HIV and Hepatitis C Virus infection among people who inject drugs in Canada. Am J Public Health. 2020;110(1):45–50. https://doi.org/10.2105/AJPH.2019.305379.
2. Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid and stimulant-related harms in Canada. Ottawa: Public Health Agency of Canada; March 202. Accessed 23 April 2021. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
3. Interactive Opioid Tool. Public Health Ontario. Accessed March 5, 2020. https://www.publichealthontario.ca/Data and Analysis/Substance Use/Interactive Opioid Tool
4. Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduct J. 2017;14(1):28. https://doi.org/10.1186/s12954-017-0154-1.
5. Supervised Consumption Services | Drug Policy Alliance. Published March 5, 2020. Accessed March 5, 2020. http://www.drugpolicy.org/issues/supervised-consumption-services
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献